Arthur D. Patten - Concepedia

Author

Arthur D. Patten

AstraZeneca (United Kingdom)

Also Known As

A D Patten, A. D. PATTEN, Arthur D. Patten, Arthur Patten, Arthur D. Patten

Publications

362

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (United Kingdom)AstraZeneca (United States)DuPont (United States)AstraZeneca (Brazil)

About

Arthur D. Patten is an author at AstraZeneca (United Kingdom) specializing in pharmacology, medicine, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	203
2	Natural Sciences	5	5	157
3	Biochemistry	5	5	187
4	Engineering	1	1	10
5	Health Sciences	1	1	41

Arthur D. Patten

Publications

358

Citations

H-Index

Page 1

	Year	Citations
Synthesis of two useful, enantiomerically pure derivatives of (S)-4-hydroxy-2-cyclohexenone James E. Audia, Louise Boisvert, Arthur D. Patten, The Journal of Organic Chemistry Derivative (Chemistry)DerivativesPure DerivativesAltmetric Attention ScoreOrganic Chemistry	1989	132
Studies relating to the synthesis of the immunosuppressive agent FK-506: coupling of fragments via a stereoselective trisubstituted olefin forming reaction sequence A. Brian Jones, Masahiko Yamaguchi, Arthur D. Patten, The Journal of Organic Chemistry Altmetric Attention ScoreOrganic ChemistryPharmaceutical ChemistryReaction SequenceMedicinal Chemistry	1989	58
A concise total synthesis of defucogilvocarcin V by application of the Meyers biaryl strategy: ortho- and para-selective functionalizations of the A ring Arthur D. Patten, Nguyen Nhan Huy, Samuel J. Danishefsky The Journal of Organic Chemistry Antimicrobial Drug DiscoveryDefucogilvocarcin VBiochemistryMedicineNatural Sciences	1988	44
In Vitro Validation of Acetyltransferase Activity of GlmU as an Antibacterial Target in Haemophilus influenzae Ed T. Buurman, Beth Andrews, Ning Gao, Journal of Biological Chemistry GlycobiologyEscherichia ColiAntimicrobial ChemotherapyDrug ResistanceMedical Microbiology	2011	41
Inhibitors of acetyltransferase domain of N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU). Part 1: Hit to lead evaluation of a novel arylsulfonamide series Oluyinka M. Green, Andrew R. McKenzie, Adam B. Shapiro, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryPharmaceutical ScienceBiochemistryMedicineNatural Sciences	2012	26
An aminoquinazoline inhibitor of the essential bacterial cell wall synthetic enzyme GlmU has a unique non-protein-kinase-like binding mode Nicholas Larsen, Tory J. Nash, Marshall Morningstar, Biochemical Journal Aminoquinazoline InhibitorCrystal StructureInhibitory ActivityBiochemistryMedicine	2012	18
XB596, a promising bis-naphthalimide anti-cancer agent S F Chen, D L Behrens, Carl H. Behrens, Anti-Cancer Drugs Tumor BiologyMedicinal ChemistryBis-naphthalimide Anti-tumor AgentsOncogenic AgentMedicine	1993	16
The synthesis and antitumor evaluation of unsymmetrical bis-imides Robert J. Cherney, Stephen G. Swartz, Arthur D. Patten, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryNatural SciencesAntitumor EvaluationChemistryPharmacology	1997	13
Photoisomerization of 4-hydroxypyrylium cations in concentrated sulfuric acid James W. Pavlik, Arthur D. Patten, David Bolin, The Journal of Organic Chemistry Chemical EngineeringChemical MeasurementEngineeringChemical AnalysisPhotochemistry	1984	10

Page 1